INFI Annual Total Liabilities
$61.20 M
-$2.01 M-3.18%
31 December 2022
Summary:
As of January 21, 2025, INFI annual total liabilities is $61.20 million, with the most recent change of -$2.01 million (-3.18%) on December 31, 2022. During the last 3 years, it has risen by +$19.91 million (+48.23%).INFI Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI Quarterly Total Liabilities
$58.64 M
+$365.00 K+0.63%
30 June 2023
Summary:
As of January 21, 2025, INFI quarterly total liabilities is $58.64 million, with the most recent change of +$365.00 thousand (+0.63%) on June 30, 2023. Over the past year, it has dropped by -$4.33 million (-6.87%).INFI Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.2% | -6.9% |
| 3 y3 years | +48.2% | -2.3% |
| 5 y5 years | +426.6% | +926.9% |
INFI Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -67.8% | -70.6% |
Infinity Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $58.64 M(+0.6%) |
| Mar 2023 | - | $58.27 M(-4.8%) |
| Dec 2022 | $61.20 M(-3.2%) | $61.20 M(-2.0%) |
| Sept 2022 | - | $62.47 M(-0.8%) |
| June 2022 | - | $62.96 M(+0.6%) |
| Mar 2022 | - | $62.60 M(-1.0%) |
| Dec 2021 | $63.21 M(+1.5%) | $63.21 M(+1.2%) |
| Sept 2021 | - | $62.47 M(+2.3%) |
| June 2021 | - | $61.06 M(+1.2%) |
| Mar 2021 | - | $60.35 M(-3.1%) |
| Dec 2020 | $62.31 M(+50.9%) | $62.31 M(+2.0%) |
| Sept 2020 | - | $61.09 M(+1.8%) |
| June 2020 | - | $60.04 M(+1.2%) |
| Mar 2020 | - | $59.34 M(+43.7%) |
| Dec 2019 | $41.29 M(+432.3%) | $41.29 M(+2.0%) |
| Sept 2019 | - | $40.49 M(+4.2%) |
| June 2019 | - | $38.87 M(+10.0%) |
| Mar 2019 | - | $35.34 M(+355.6%) |
| Dec 2018 | $7.76 M(-33.3%) | $7.76 M(+26.3%) |
| Sept 2018 | - | $6.14 M(+7.5%) |
| June 2018 | - | $5.71 M(+25.0%) |
| Mar 2018 | - | $4.57 M(-60.7%) |
| Dec 2017 | $11.62 M(-73.1%) | $11.62 M(+6.7%) |
| Sept 2017 | - | $10.90 M(-65.9%) |
| June 2017 | - | $31.94 M(+7.1%) |
| Mar 2017 | - | $29.82 M(-31.0%) |
| Dec 2016 | $43.20 M(-77.3%) | $43.20 M(-13.2%) |
| Sept 2016 | - | $49.78 M(-27.3%) |
| June 2016 | - | $68.46 M(-61.7%) |
| Mar 2016 | - | $178.85 M(-6.0%) |
| Dec 2015 | $190.26 M(+19.2%) | $190.26 M(-4.7%) |
| Sept 2015 | - | $199.62 M(+29.9%) |
| June 2015 | - | $153.62 M(+4.8%) |
| Mar 2015 | - | $146.56 M(-8.2%) |
| Dec 2014 | $159.67 M(+442.5%) | $159.67 M(+5.5%) |
| Sept 2014 | - | $151.31 M(+458.3%) |
| June 2014 | - | $27.10 M(+1.4%) |
| Mar 2014 | - | $26.73 M(-9.2%) |
| Dec 2013 | $29.43 M(+15.6%) | $29.43 M(-3.7%) |
| Sept 2013 | - | $30.55 M(+9.8%) |
| June 2013 | - | $27.82 M(+15.3%) |
| Mar 2013 | - | $24.13 M(-5.2%) |
| Dec 2012 | $25.45 M(-76.7%) | $25.45 M(+37.9%) |
| Sept 2012 | - | $18.46 M(-84.1%) |
| June 2012 | - | $116.44 M(+7.9%) |
| Mar 2012 | - | $107.96 M(-1.0%) |
| Dec 2011 | $109.06 M | $109.06 M(+56.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | $69.63 M(+4.8%) |
| June 2011 | - | $66.42 M(+0.8%) |
| Mar 2011 | - | $65.89 M(-12.2%) |
| Dec 2010 | $75.08 M(+12.1%) | $75.08 M(+17.9%) |
| Sept 2010 | - | $63.69 M(+24.0%) |
| June 2010 | - | $51.34 M(-2.4%) |
| Mar 2010 | - | $52.61 M(-21.5%) |
| Dec 2009 | $67.01 M(+66.2%) | $67.01 M(+23.0%) |
| Sept 2009 | - | $54.48 M(-3.7%) |
| June 2009 | - | $56.58 M(-0.4%) |
| Mar 2009 | - | $56.79 M(+40.8%) |
| Dec 2008 | $40.32 M(-48.7%) | $40.32 M(-34.4%) |
| Sept 2008 | - | $61.49 M(-5.0%) |
| June 2008 | - | $64.71 M(-1.6%) |
| Mar 2008 | - | $65.78 M(-16.3%) |
| Dec 2007 | $78.58 M(-14.8%) | $78.58 M(+0.1%) |
| Sept 2007 | - | $78.53 M(-3.3%) |
| June 2007 | - | $81.17 M(-3.5%) |
| Mar 2007 | - | $84.13 M(-8.8%) |
| Dec 2006 | $92.22 M(+545.9%) | $92.22 M(-15.5%) |
| Sept 2006 | - | $109.13 M(+2037.8%) |
| June 2006 | - | $5.10 M(-21.4%) |
| Mar 2006 | - | $6.50 M(-54.5%) |
| Dec 2005 | $14.28 M(+97.3%) | $14.28 M(+110.3%) |
| Sept 2005 | - | $6.79 M(-11.5%) |
| June 2005 | - | $7.67 M(+8.5%) |
| Mar 2005 | - | $7.07 M(-2.3%) |
| Dec 2004 | $7.24 M(-33.8%) | $7.24 M(+4.9%) |
| Sept 2004 | - | $6.90 M(-21.2%) |
| June 2004 | - | $8.76 M(+14.4%) |
| Mar 2004 | - | $7.66 M(-30.0%) |
| Dec 2003 | $10.94 M(+38.2%) | $10.94 M(+36.9%) |
| Sept 2003 | - | $7.99 M(-8.8%) |
| June 2003 | - | $8.76 M(+16.3%) |
| Mar 2003 | - | $7.53 M(-4.8%) |
| Dec 2002 | $7.91 M(-17.7%) | $7.91 M(-19.9%) |
| Sept 2002 | - | $9.88 M(+1.6%) |
| June 2002 | - | $9.72 M(+0.5%) |
| Mar 2002 | - | $9.67 M(+0.6%) |
| Dec 2001 | $9.61 M(-13.4%) | $9.61 M(-14.9%) |
| Sept 2001 | - | $11.29 M(+8.4%) |
| June 2001 | - | $10.42 M(+3.1%) |
| Mar 2001 | - | $10.10 M(-9.0%) |
| Dec 2000 | $11.10 M(-14.7%) | $11.10 M(-2.1%) |
| Sept 2000 | - | $11.34 M(-16.2%) |
| June 2000 | - | $13.53 M(+0.9%) |
| Mar 2000 | - | $13.40 M |
| Dec 1999 | $13.01 M | - |
FAQ
- What is Infinity Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals annual total liabilities year-on-year change?
- What is Infinity Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals quarterly total liabilities year-on-year change?
What is Infinity Pharmaceuticals annual total liabilities?
The current annual total liabilities of INFI is $61.20 M
What is the all time high annual total liabilities for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high annual total liabilities is $190.26 M
What is Infinity Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, INFI annual total liabilities has changed by -$2.01 M (-3.18%)
What is Infinity Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of INFI is $58.64 M
What is the all time high quarterly total liabilities for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high quarterly total liabilities is $199.62 M
What is Infinity Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, INFI quarterly total liabilities has changed by -$4.33 M (-6.87%)